Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis

Retina

Volumn 26, Issue 4, 2006, Pages 396-403

  Mauget Faÿsse, Martine ^a   Mimoun, Gérard ^b   Ruiz Moreno, José M ^c   Maftouhi, Maddalena Quaranta El ^a   De Laey, Jean J ^d   Postelmans, Laurence ^b   Soubrane, Gisèle ^b   Defauchy, Michel ^b   Leys, Anita ^e  

^a Centre Ophtalmologique Rabelais   (France)

^b Facultad de Medicina ^*

^c Facultad de Medicina   (Spain)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Choroidal neovascularization; Photodynamic therapy; Retinochoroiditis; Toxoplasma; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FOLINATE CALCIUM; PYRIMETHAMINE; SULFADOXINE; COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; PHOTOSENSITIZING AGENT; PORPHYRIN; PROTOZOON ANTIBODY;

ADULT; ARTICLE; BLOOD VESSEL SHUNT; CHORIORETINITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TOXOPLASMA; VISUAL ACUITY; VISUAL IMPAIRMENT; ADOLESCENT; BLOOD; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; PARASITOLOGY; PHOTOCHEMOTHERAPY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CHORIORETINITIS; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TOXOPLASMOSIS, OCULAR; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33745069090     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200604000-00003     Document Type: Article

References (30)

1. Schlaegel TF Jr, Weber JC. The macula in ocular toxoplasmosis. Arch Ophthalmol 1984;102:697-698.
2. Skorska I, Soubrane G, Coscas G. Toxoplasmic choroiditis and subretinal new vessels. J Fr Ophtalmol 1984;7:211-218.
3. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 2004;48:386-391.
4. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: twoyear results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 2001;119:198-207 .
5. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 2001;131:541-560.
6. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. One-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852.
7. Aaberg TM, VOH Study Group. Four-year results of verteporfin therapy for choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS): second year of an open-label extension of the VOH Study. Invest Ophthalmol Vis Sci 2004; 45: EAbstract 2278.
8. Tabbara KF. Disruption of the choroidoretinal interface by toxoplasmia. Eye 1990;4:366-373.
9. Gass JMD. Pathogenesis of disciform detachment of the neuroepithelium. V. Disciform macular degeneration secondary to focal choroiditis. Am J Ophthalmol 1967;63:661-686.
10. Friedman CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;18:481-493.
11. Fine SL, Owens SL, Heller JA, et al. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol 1981;91:318-322.
12. Cotliar AM, Friedman AM. Subretinal neovascularization in ocular toxoplasmosis. Br J Ophthalmol 1982;66:524-529.
13. Goshorn EB, Hoover DL, Eller AW, et al. Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus 1995;32:178-182.
14. Spraul CW, Grossniklaus HE. Characteristics of drusen and Bruch's membrane in post-mortem eyes with age-related macular degeneration. Arch Ophthalmol 1997;115:267-273.
15. Bernasconi O, Auer C, Herbort CP. Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm 1997;5:207-211.
16. Melberg NS, Thomas MA, Burgess DB. The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome. Retina 1996;16:190-195.
17. Sears J, Capone A Jr, Aaberg T Sr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology 1999;106:920-924.
18. Adan A, Mateo C, Wolley-Dod C. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. Am J Ophthalmol 2003;135:386-387.
19. Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol 2000;118:1373-1378.
20. Wang LK, Kansal S, Pulido JS. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Am J Ophthalmol 2002;134:790-792.
21. Monshizadeh R, Ashrafzadeh MT, Rumelt S. Choroidal neovascular membrane: a late complication of inactive toxocara chorioretinitis. Retina 2000;20:219-220.
22. Farah ME, Costa RA, Muccioli C, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2002;134:137-139.
23. Coquelet P, Postelmans L, Snyers B, Verougstraete C. Successful photodynamic therapy combined with laser photocoagulation in three eyes with classic neovascularization affecting two patients with multifocal choroiditis: case reports. Bull Soc Belge Ophtalmol 2002;283:69-73.
24. Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-68.
25. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-336.
26. Rogers AH, Duker JS, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003;110:1315-1320.
27. Mimouni KF, Bressler SB, Bressler NM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol 2003;135:900-902.
28. Oliveira LB, Reis PA. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol 2004;242:1028-1030.
29. Nessi F, Guex-Crosier Y, Ambresin A, Zografos L. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to toxoplasmic chorioretinal scar. Klin Monatsbl Augenheilkd 2004;221:371-373.
30. Potter JW. Vascular anastomoses in ocular toxoplasmosis. J Am Optom Assoc 1982;53:549-552.